Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2L1 | Q07817 | 5/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 5/20 | 0.42 |
| ▸ | CASP3 | P42574 | 5/20 | 0.37 |
| ▸ | P4HTM | Q9NXG6 | 3/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9515729 | 0.92 | BCL2L1 (0.40) | BCL2L1MCL1CASP3P4HTMHDAC6 | |
| SCHEMBL9516990 | 0.89 | P4HTM (0.37) | CASP3P4HTMHDAC6 | |
| SCHEMBL9515748 | 0.84 | P4HTM (0.39) | CASP3P4HTMHDAC6L3MBTL1NPC1 | |
| SCHEMBL9517314 | 0.84 | P4HTM (0.36) | CASP3P4HTMHDAC6 | |
| SCHEMBL9516087 | 0.84 | BCL2L1 (0.38) | BCL2L1MCL1CASP3P4HTM | |
| SCHEMBL9517165 | 0.84 | VNN1 (0.40) | BCL2L1MCL1HDAC6 | |
| SCHEMBL9519638 | 0.83 | BCL2L1 (0.42) | BCL2L1MCL1P4HTMHDAC6LMNA | |
| SCHEMBL9517937 | 0.80 | EGFR (0.40) | CASP3P4HTMNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL9516974 | 0.76 | EGFR (0.44) | CASP3P4HTMHDAC6L3MBTL1NPC1 | |
| SCHEMBL9515738 | 0.76 | P4HTM (0.43) | BCL2L1MCL1P4HTMHDAC6LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0567997-A1 | 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-11-03 | — | — | EP | disclosed |